Nifty
:
24583.80
Sensex
:
78542.44
13.15 (0.05%)
43.27 (0.06%)
Nifty
Sensex
:
:
24583.80
78542.44
13.15 (0.05%)
43.27 (0.06%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
54/99

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
1069.00
10-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1070.2
  •  1079.9
  •  1054.3
  •  1070.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2126362
  •  2268432040.8
  •  1301.7
  •  903

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,04,140.26
  • 72.20
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,06,346.48
  • 0.19%
  • 9.82

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.71%
  • 0.23%
  • 3.22%
  • FII
  • DII
  • Others
  • 41.78%
  • 26.19%
  • 4.87%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.94
  • 16.29
  • 15.70

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.92
  • 19.02
  • 8.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 18.98
  • 10.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 72.58
  • 79.66

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.69
  • 10.35

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 45.43
  • 49.72

Earnings Forecasts:

(Updated: 08-08-2026)
Description
2026
2027
2028
2029
Adj EPS
57
0
20.01
16.99
P/E Ratio
18.75
-
53.42
62.92
Revenue
56.44
46.07
38.34
10041.2
EBITDA
11896.8
14099.5
16623.3
2620.18
Net Income
3138.18
3776.33
4496.9
1662.87
ROA
1929.82
2366.11
2826.59
10.81
P/B Ratio
0.62
1.37
-0.65
8.82
ROE
8.12
6.98
5.9
15.45
FCFF
15.04
15.82
16.09
142.68
FCFF Yield
479.35
1212.45
1787.84
0.13
Net Debt
0.43
1.08
1.59
1954.71
BVPS
1730.13
780.4
-1647.68
121.24

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
2,142.89
1,909.74
12.21%
2,067.52
1,868.31
10.66%
2,135.47
1,707.46
25.07%
2,027.57
1,542.95
31.41%
Expenses
1,536.46
1,398.12
9.89%
1,529.18
1,369.18
11.69%
1,560.32
1,256.92
24.14%
1,504.66
1,155.54
30.21%
EBITDA
606.43
511.62
18.53%
538.34
499.13
7.86%
575.15
450.54
27.66%
522.91
387.41
34.98%
EBIDTM
28.30%
26.79%
26.04%
26.72%
26.93%
26.39%
25.79%
25.11%
Other Income
47.83
46.92
1.94%
45.38
33.30
36.28%
32.90
40.84
-19.44%
36.51
34.68
5.28%
Interest
66.66
55.21
20.74%
59.67
52.39
13.90%
53.92
33.54
60.76%
54.85
23.88
129.69%
Depreciation
123.02
100.83
22.01%
111.27
97.54
14.08%
108.10
84.15
28.46%
104.14
76.90
35.42%
PBT
464.58
402.50
15.42%
364.54
308.87
18.02%
446.03
373.69
19.36%
400.43
321.31
24.62%
Tax
122.36
83.50
46.54%
63.62
70.07
-9.21%
-45.27
91.88
-
92.46
85.04
8.73%
PAT
342.22
319.00
7.28%
300.92
238.80
26.01%
491.30
281.81
74.34%
307.97
236.27
30.35%
PATM
15.97%
16.70%
14.55%
12.78%
23.01%
16.50%
15.19%
15.31%
EPS
3.52
3.28
7.32%
3.09
2.46
25.61%
5.05
2.90
74.14%
3.17
2.43
30.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
8,373.45
7,028.46
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,729.13
1,608.26
Net Sales Growth
-
19.14%
30.01%
18.49%
15.90%
56.96%
136.82%
-37.37%
-2.20%
7.52%
 
Cost Of Goods Sold
-
1,790.02
1,477.05
1,118.52
922.01
922.90
594.41
217.31
364.46
425.90
423.10
Gross Profit
-
6,583.43
5,551.41
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,303.23
1,185.16
GP Margin
-
78.62%
78.98%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
75.37%
73.69%
Total Expenditure
-
6,132.57
5,188.03
3,924.88
3,335.14
2,998.14
2,124.34
970.38
1,545.51
1,616.35
1,467.93
Power & Fuel Cost
-
121.64
115.03
77.54
69.04
62.67
51.37
22.72
46.06
41.36
40.90
% Of Sales
-
1.45%
1.64%
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.39%
2.54%
Employee Cost
-
1,357.12
1,174.01
934.40
809.35
759.92
588.78
230.13
440.55
422.91
353.47
% Of Sales
-
16.21%
16.70%
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
24.46%
21.98%
Manufacturing Exp.
-
2,177.23
1,800.27
1,348.42
1,195.50
995.21
670.35
336.05
112.01
123.23
105.32
% Of Sales
-
26.00%
25.61%
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
7.13%
6.55%
General & Admin Exp.
-
586.09
507.53
382.92
303.70
226.23
165.14
129.84
563.52
588.57
526.48
% Of Sales
-
7.00%
7.22%
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
34.04%
32.74%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
100.47
114.14
63.08
35.54
31.21
54.29
34.33
18.91
14.38
0.00
% Of Sales
-
1.20%
1.62%
1.17%
0.78%
0.79%
2.16%
3.24%
1.12%
0.83%
1.16%
EBITDA
-
2,240.88
1,840.43
1,481.14
1,227.46
938.41
383.63
88.65
145.51
112.78
140.33
EBITDA Margin
-
26.76%
26.19%
27.40%
26.90%
23.84%
15.30%
8.37%
8.60%
6.52%
8.73%
Other Income
-
164.57
164.01
189.05
152.31
131.51
134.97
53.01
66.72
54.52
42.37
Interest
-
235.10
165.02
59.89
83.86
100.87
179.46
83.24
101.27
99.37
99.68
Depreciation
-
446.53
359.42
244.98
232.19
221.12
174.09
45.64
102.64
94.42
95.51
PBT
-
1,723.82
1,480.00
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-26.49
-12.49
Tax
-
233.17
330.49
307.68
-39.79
133.85
45.85
-0.13
8.51
2.24
-11.09
Tax Rate
-
13.92%
23.50%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
-8.46%
88.79%
PAT
-
1,442.41
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-32.07
-1.40
PAT before Minority Interest
-
1,442.41
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-28.73
-1.40
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
-3.34
0.00
PAT Margin
-
17.23%
15.31%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-1.85%
-0.09%
PAT Growth
-
34.07%
1.72%
-4.16%
82.38%
-
-
-
-
-
 
EPS
-
14.82
11.06
10.87
11.34
6.22
-1.18
0.13
-0.03
-0.33
-0.01

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
10,746.63
9,380.87
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
1,166.74
1,192.38
Share Capital
973.13
972.14
971.91
970.92
969.61
965.95
537.24
537.24
537.24
537.24
Total Reserves
9,626.72
8,289.06
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
629.50
655.14
Non-Current Liabilities
4,250.88
3,999.40
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
1,792.13
1,646.95
Secured Loans
2,438.66
2,270.06
1,060.33
496.08
628.91
842.32
105.73
889.10
848.57
771.87
Unsecured Loans
0.00
0.00
0.50
0.50
0.50
0.50
0.50
0.96
0.00
0.00
Long Term Provisions
127.82
105.67
75.47
60.48
59.79
60.19
40.66
17.33
15.64
13.59
Current Liabilities
2,186.94
1,806.17
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
478.09
380.11
Trade Payables
859.04
800.32
633.01
543.46
444.11
435.69
179.63
291.59
266.51
213.72
Other Current Liabilities
1,154.43
863.43
493.26
408.16
196.95
247.56
95.26
758.66
92.79
65.84
Short Term Borrowings
92.04
63.59
61.29
45.58
74.53
54.25
727.37
73.68
104.36
87.05
Short Term Provisions
81.43
78.83
61.15
48.37
41.68
39.43
7.69
16.10
14.43
13.50
Total Liabilities
17,184.45
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
3,304.22
3,146.10
Net Block
12,986.40
11,496.93
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
2,227.18
2,244.24
Gross Block
15,116.88
13,337.70
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
2,464.32
2,422.67
Accumulated Depreciation
2,130.48
1,840.77
1,181.77
919.67
742.02
562.84
401.21
365.00
237.14
178.43
Non Current Assets
15,239.66
13,593.87
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
2,872.03
2,796.68
Capital Work in Progress
593.05
900.72
553.04
252.43
151.12
26.93
27.55
87.02
38.30
46.14
Non Current Investment
5.46
2.89
2.12
0.51
0.51
0.51
0.00
0.51
0.00
0.00
Long Term Loans & Adv.
1,396.94
951.31
727.51
673.93
757.17
679.63
70.06
535.51
512.24
373.31
Other Non Current Assets
253.15
237.36
227.40
193.21
262.46
175.54
109.71
91.83
94.31
132.99
Current Assets
1,944.79
1,592.57
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
432.19
349.12
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
2,182.06
0.00
0.00
0.00
Inventories
114.28
106.21
79.84
76.23
61.36
53.80
26.80
26.01
28.27
23.12
Sundry Debtors
969.75
687.31
462.69
336.12
385.36
365.89
96.09
362.61
257.92
234.82
Cash & Bank
700.60
681.89
1,099.27
1,468.07
499.31
652.92
119.57
11.64
89.97
22.75
Other Current Assets
160.16
41.25
23.46
14.06
54.26
51.86
490.87
47.04
56.03
68.43
Short Term Loans & Adv.
116.10
75.91
40.92
48.59
30.27
37.39
478.76
36.06
42.43
49.64
Net Current Assets
-242.15
-213.60
457.47
897.50
243.02
347.54
1,905.44
-692.73
-45.90
-30.99
Total Assets
17,184.45
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
3,304.22
3,145.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,633.32
1,437.96
1,121.67
1,284.13
740.52
117.86
77.09
88.95
PBT
1,675.58
1,406.37
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
592.32
477.22
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-262.68
-124.69
-159.22
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
2,005.22
1,758.90
1,390.95
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-371.90
-320.94
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,688.99
-1,610.69
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-384.37
-307.51
-450.46
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-11.93
-698.35
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-1,292.69
-604.83
-394.37
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
59.27
-163.16
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
3.60
-335.89
-427.52
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
661.58
979.84
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
665.80
661.58
979.71
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
108.93
95.27
85.82
75.89
64.57
58.10
47.52
17.93
ROA
8.91%
7.91%
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
14.53%
12.22%
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
14.97%
14.67%
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.59
0.60
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
36.12
29.86
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
4.81
4.83
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
169.18
177.10
191.96
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-128.26
-142.41
-159.72
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.27
0.27
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
8.13
9.52
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Max Healthcare Institute reports 7% rise in Q4FY26 consolidated net profit
    22nd May 2026, 12:14 PM

    Consolidated total income of the company increased by 11.96% at Rs 2,190.72 crore for Q4FY26

    Read More
  • Max Healthcare gets nod to construct phase-I of Max Super Specialty Hospital in Lucknow
    22nd May 2026, 09:30 AM

    The board of directors of the Company, at their meeting held on May 21, 2026, has approved the same

    Read More
  • Max Healthcare Inst - Quarterly Results
    22nd May 2026, 00:00 AM

    Read More
  • Max Healthcare Institute completes acquisition of controlling stake in Kalinga Hospital
    19th May 2026, 10:19 AM

    Kalinga Hospital has become a subsidiary of the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.